Philip Comp to Thrombin
This is a "connection" page, showing publications Philip Comp has written about Thrombin.
Connection Strength
0.217
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
Score: 0.071
-
Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood. 1984 Jan; 63(1):15-21.
Score: 0.053
-
Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine. Transplantation. 1991 Mar; 51(3):701-5.
Score: 0.022
-
Animal studies of protein C physiology. Semin Thromb Hemost. 1984 Apr; 10(2):149-53.
Score: 0.013
-
The activation and effects of protein C, an antithrombotic protein, in vivo. Surv Synth Pathol Res. 1984; 3(1):31-7.
Score: 0.013
-
Activation of protein C in vivo. J Clin Invest. 1982 Jul; 70(1):127-34.
Score: 0.012
-
Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest. 1981 Nov; 68(5):1221-8.
Score: 0.011
-
Activated protein C inhibits platelet prothrombin-converting activity. Blood. 1979 Dec; 54(6):1272-81.
Score: 0.010
-
Cytokine-induced alteration of platelet and hemostatic function. Stem Cells. 1996; 14 Suppl 1:154-62.
Score: 0.008
-
Biochemical and physiological aspects of protein c. Ric Clin Lab. 1984 Jul-Sep; 14(3):455-68.
Score: 0.003